This webinar will be hosted live and available on-demand
Thursday, October 26, 2023
10:00-11:00 AM ET (4:00-5:00 PM CET)
Although cellular immunotherapy can achieve good outcomes, only a small proportion of cancer patients are being treated via this approach, with extremely long waitlists. Furthermore, applying centralized manufacturing workflows to individualized products results in complex logistics, creating laborious and non-standardized processes that elevate drug costs.
In this webinar brought to you by Bruker, Patrick Schmidt will highlight how combining rapid large-scale transfection technology with single cell-based selection can shorten CAR T product manufacturing times.
 | Patrick Schmidt, PhD |
